$RXRX stock fell 18% this week. Here's what we see in our data.

$RXRX stock fell 18% this week, according to our price data from Polygon.

It has been the 42nd most-searched ticker on Quiver Quantitative over the last week, out of 50 total tickers searched.

Here is what we see in our data on $RXRX (you can track the company live on Quiver's $RXRX stock page):

$RXRX Insider Trading Activity

$RXRX insiders have traded $RXRX stock on the open market 20 times in the past 6 months. Of those trades, 0 have been purchases and 20 have been sales.

Here’s a breakdown of recent trading of $RXRX stock by insiders over the last 6 months:

BLAKE BORGESON has made 0 purchases and 6 sales selling 520,000 shares for an estimated $1,979,700.
CHRISTOPHER GIBSON has made 0 purchases and 8 sales selling 320,000 shares for an estimated $1,148,400.
NAJAT KHAN (CEO and President) has made 0 purchases and 2 sales selling 51,886 shares for an estimated $179,118.
BEN R TAYLOR (Chief Financial Officer) has made 0 purchases and 2 sales selling 21,382 shares for an estimated $68,322.
NAMANDJE BUMPUS has made 0 purchases and 2 sales selling 8,349 shares for an estimated $28,128.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$RXRX Hedge Fund Activity

We have seen 157 institutional investors add shares of $RXRX stock to their portfolio, and 107 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

NOVO HOLDINGS A/S removed 7,929,835 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $24,344,593
BLACKROCK, INC. added 4,325,527 shares (+11.1%) to their portfolio in Q1 2026, for an estimated $13,279,367
GOLDMAN SACHS GROUP INC added 3,864,219 shares (+175.5%) to their portfolio in Q1 2026, for an estimated $11,863,152
CITADEL ADVISORS LLC removed 3,605,340 shares (-85.2%) from their portfolio in Q1 2026, for an estimated $11,068,393
MORGAN STANLEY removed 3,472,249 shares (-61.4%) from their portfolio in Q1 2026, for an estimated $10,659,804
STATE STREET CORP added 3,156,750 shares (+12.5%) to their portfolio in Q1 2026, for an estimated $9,691,222
MARSHALL WACE, LLP added 2,650,319 shares (+1169.6%) to their portfolio in Q1 2026, for an estimated $8,136,479

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

EARLY ACCESS

Receive RXRX Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

$RXRX Price Targets

Multiple analysts have issued price targets for $RXRX recently. We have seen 4 analysts offer price targets for $RXRX in the last 6 months, with a median target of $7.0.

Here are some recent targets:

Vikram Purohit from Morgan Stanley set a target price of $5.5 on 05/14/2026
Gil Blum from Needham set a target price of $8.0 on 05/07/2026
Priyanka Grover from JP Morgan set a target price of $10.0 on 04/30/2026
Michael Ryskin from B of A Securities set a target price of $6.0 on 02/26/2026

You can track data on $RXRX on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.